Plain-English translation of NCT06915038 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a blood test that detects HPV DNA can help personalize treatment for people with HPV-positive throat or tonsil cancer. After you have surgery to remove the tumor, doctors will check your blood for traces of the cancer-causing virus. Based on those results, you may need less intensive follow-up treatment — or perhaps none at all — while still getting excellent outcomes.
Currently, all patients with this type of throat cancer receive the same follow-up treatments, which can cause serious side effects and long-term problems. Doctors believe that a simple blood test could identify which patients truly need additional treatment and which ones could safely skip it or receive gentler versions, reducing harm without sacrificing results.
You likely qualify if…
You likely don't qualify if…
You will have surgery to remove your tumor, and then your blood will be tested for HPV DNA at several points afterward. Depending on those blood test results and the characteristics of your tumor, you will either be monitored closely without further treatment, receive mild radiation (30 units), or receive standard-dose radiation (40 units). The study involves regular follow-up visits and imaging to monitor your progress.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States